In 2121, Dr. Klaus Jäger and colleagues at Luna Research Dome 4 published the first full biochemical characterization of material reverse-engineered from tissue and notation samples recovered during the 2105 Dominium Hominis raid — what the cult had called “black blood.”
The Compound
MHA-1 (melanized hemoprotein analogue) incorporates a melanin-derived pigment structure covalently integrated into a modified hemoprotein scaffold. The mechanism is distinct from the Svarog programme’s SVR-class compounds: rather than mitigating radiation damage after exposure through metabolic and cellular-repair mechanisms, MHA-1 converts a measurable fraction of incident ionizing radiation into dissipated chemical energy at the point of interaction — analogous to radiosynthetic processes documented in melanized fungal organisms from high-radiation terrestrial environments. This is the first demonstration of the mechanism integrated into a functional mammalian oxygen-transport protein.
Results
Murine trials (n=340, 2118–2120) showed statistically significant reduction in radiation-induced cellular damage relative to controls (p<0.01), with oxygen transport efficiency 6–9% above unmodified baseline. Subsequent chimpanzee trials (n=12, 2120–2121) replicated both findings with comparable safety profiles. No adverse hematological, hepatic, or renal findings were observed in either population. Human Phase I trials are scheduled for 2124.
The paper also reported preliminary findings on skeletal density modification — another Dominium Hominis research line, observed in surviving children as apparent congenital skeletal restructuring. Attempts to replicate density-enhancing effects in adult subjects were unsuccessful; the original modification was applied gestationally. A pharmacological derivative administered post-natally demonstrated measurable reduction in bone-density loss rate under simulated microgravity, presented as complementary to existing countermeasures (e.g., Ceres gravity-loop therapy) rather than a replacement.
Provenance
The paper’s ethical statement was not a footnote but a condition of publication. The original material derived from non-consensual and, in multiple documented cases, fatal self-experimentation and experimentation on minors, conducted entirely outside any recognized ethical or regulatory framework. The material was held under UNSF evidentiary custody until 2109, when limited research access was granted to Dome 4 under OETG oversight. No original human subjects were research participants of Dome 4; all animal trials were conducted under standard UN ethical review. The statement explicitly directed readers to Dome 4’s accompanying institutional statement on research provenance.